31081-59-1

Basic information

• Product Name: OCTADECYLMETHANESULFONATE
• Synonyms: OCTADECYLMETHANESULFONATE
• CAS NO: 31081-59-1
• Molecular Formula: C₁₉H₄₀O₃S
• Molecular Weight: 348.58
• Mol File: 31081-59-1.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 454.1°C at 760 mmHg
• Flash Point: 228.5°C
• Appearance: /
• Density: 0.943g/cm³
• Vapor Pressure: 5.26E-08mmHg at 25°C
• Refractive Index: 1.456
• CAS DataBase Reference: OCTADECYLMETHANESULFONATE(CAS DataBase Reference)
• NIST Chemistry Reference: OCTADECYLMETHANESULFONATE(31081-59-1)
• EPA Substance Registry System: OCTADECYLMETHANESULFONATE(31081-59-1)

Safety Data

• Hazardous Substances Data: 31081-59-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C19H40O3S/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22-23(2,20)21/h3-19H2,1-2H3

Upstream product

• 1731-94-8 nonadecanoic acid methyl ester 
• 112-92-5 1-octadecanol 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 6297-03-6 19-oxaheptatriacontane 
• 6076-42-2 1,2,3-tri(octadecyloxy)propane 
• 18794-74-6 1,3-bis(octadecyloxy)-2-propanol 
• 16725-43-2 4-(n-octadecyloxymethyl)-2,2-dimethyl-1,3-dioxolane 
• 101007-72-1 4-Octadecyloxymethyl-2-phenyl-4,5-dihydro-oxazole 
• 2136-72-3 3-oxa-1-heneicosanol 
• 197306-92-6 1-octadecyl-2,3-dibenzylglycerol 
• 144944-50-3 rac-1-(benzylsulfanyl)-2,3-bis(octadecyloxy)propane 
• 40630-77-1 1-O-benzoyl3-O-octadecyl-sn-glycerol 
• 55378-61-5 2,3-di-O-benzoyl-1-O-octadecyl-sn-glycerol 
• 104478-41-3 Benzoic acid (R)-1-hydroxymethyl-2-octadecyloxy-ethyl ester 
• 113897-22-6 2-Octadecyloxymethyl-3-[2-(3-phenyl-propyl)-[1,3]dithian-2-yl]-propan-1-ol 
• 140193-15-3 3-{2-[3-(tert-Butyl-dimethyl-silanyloxy)-2-octadecyloxymethyl-propyl]-[1,3]dithian-2-yl}-cyclohexanone 
• 113897-54-4 C₃₇H₆₈NO₆P 

Relevant articles and documents

-

-

Multicompartment Theranostic Nanoemulsions Stabilized by a Triphilic Semifluorinated Block Copolymer

The presence of a perfluorocarbon block in a multiblock polymer has been shown to be an additional driving force toward nanoparticle assembly. In the preparation of nanoemulsions, this perfluorocarbon block also provides enhanced particle stability. Herei

Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles

The present invention provides therapeutic formulations, including therapeutic nanoemulsions, and related methods for the in vivo delivery of hydrophobic compounds. Formulations and methods of the invention include semifluorinated block copolymers and an

Lipid Compounds Targeting VLA-4

The invention relates to the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein n, G, W, X, Y, and R1 are defined in the detailed description and claims. The compounds of formula I bind to or associate with VLA-4 and can be used in delivery formulations to deliver drugs, nucleic acids, or other therapeutic compounds to tissues or cells expressing VLA-4.